CLINICAL_TRIALS
research
· 2026-01-16
Clinical Trial Update: Volatile Organic Compounds Analysis by PTR-TOF-MS for Screening Respiratory Infections Using Exhaled Breath. [NA]
Summary
Clinical trial evaluating volatile organic compounds in exhaled breath using PTR-TOF-MS as a screening tool for respiratory infections, including COVID-19, whic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: COVID-19 Infections, Respiratory Infections, Acute | NA | Status: NOT_YET_RECRUITING